Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about TPM2: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
TPM2 is a gene implicated in neurodegeneration research. Key relationships include: associated with, therapeutic target, regulates. Associated with Diabetes, Inflammation, Ms. Connected to 60 entities in the SciDEX knowledge graph.
| Gene Symbol | TPM2 |
| Full Name | Tropomyosin 2 |
| Chromosome | 9p13.3 |
| Function | Mechanism |
| Amino Acids | 284 aa |
| Pathways | Oxidative Stress |
| GeneCards | TPM2 |
| Human Protein Atlas | TPM2 |
| Thin filament formation | Co-polymerizes with actin |
| Troponin complex interaction | Binds troponin T |
| Myosin binding site exposure | Controls access to myosin binding sites |
| Calcium regulation | Part of troponin-tropomyosin complex |
| Interactor | Function |
| Actin | Filament formation |
| Troponin complex | Calcium regulation |
| Associated Diseases | Diabetes, Inflammation, PD, Parkinson |
| KG Connections | 74 knowledge graph edges |
| Databases | GeneCardsUniProtNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
TPM2["<b>TPM2</b>"]
NEFL["NEFL"]
TPM2 -->|"binds"| NEFL
INA["INA"]
TPM2 -->|"binds"| INA
GIG["GIG"]
TPM2 -->|"binds"| GIG
ELANE["ELANE"]
TPM2 -->|"regulates"| ELANE
IL1B["IL1B"]
TPM2 -->|"regulates"| IL1B
IL8["IL8"]
TPM2 -->|"regulates"| IL8
RAC1["RAC1"]
TPM2 -->|"associated with"| RAC1
MGA["MGA"]
TPM2 -->|"associated with"| MGA
DENND3["DENND3"]
TPM2 -->|"associated with"| DENND3
Inflammation{"Inflammation"}
TPM2 -->|"therapeutic target"| Inflammation
Ms{"Ms"}
TPM2 -->|"therapeutic target"| Ms
Parkinson{"Parkinson"}
TPM2 -->|"therapeutic target"| Parkinson
SOD2["SOD2"]
SOD2 -->|"therapeutic target"| TPM2
CDC42["CDC42"]
CDC42 -->|"therapeutic target"| TPM2
CYCS["CYCS"]
CYCS -->|"therapeutic target"| TPM2
GFAP["GFAP"]
GFAP -->|"therapeutic target"| TPM2
RAC1 -->|"regulates"| TPM2
MET["MET"]
MET -->|"therapeutic target"| TPM2
MMP9["MMP9"]
MMP9 -->|"therapeutic target"| TPM2
VIM["VIM"]
VIM -->|"therapeutic target"| TPM2
style TPM2 fill:#1a3a4a,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| NEFL | binds | protein | 0.80 |
| GIG | binds | protein | 0.80 |
| ELANE | regulates | protein | 0.80 |
| IL1B | regulates | protein | 0.80 |
| Type 2 Diabetes Mellitus with Parkinson's Disease | upregulates | disease | 0.80 |
| INA | binds | protein | 0.80 |
| IL8 | regulates | protein | 0.80 |
| Type 2 Diabetes Mellitus | upregulates | disease | 0.75 |
| RAC1 | associated_with | gene | 0.70 |
| MGA | associated_with | gene | 0.70 |
| DENND3 | associated_with | gene | 0.70 |
| Inflammation | therapeutic_target | disease | 0.65 |
| Ms | therapeutic_target | disease | 0.65 |
| Parkinson | therapeutic_target | disease | 0.65 |
| Diabetes | therapeutic_target | disease | 0.65 |
| Parkinson | associated_with | disease | 0.65 |
| Inflammation | associated_with | disease | 0.65 |
| Diabetes | associated_with | disease | 0.65 |
| PD | associated_with | disease | 0.60 |
| NCF1 | therapeutic_target | gene | 0.60 |
| SOD2 | therapeutic_target | gene | 0.60 |
| GFAP | therapeutic_target | gene | 0.60 |
| VIM | therapeutic_target | gene | 0.60 |
| MMP9 | therapeutic_target | gene | 0.60 |
| CDC42 | therapeutic_target | gene | 0.60 |
| RAC1 | regulates | gene | 0.60 |
| CYCS | therapeutic_target | gene | 0.60 |
| CALD1 | associated_with | gene | 0.60 |
| CYCS | associated_with | gene | 0.60 |
| CDC42 | associated_with | gene | 0.60 |
| VIM | associated_with | gene | 0.60 |
| MET | associated_with | gene | 0.60 |
| GFAP | associated_with | gene | 0.60 |
| NCF1 | associated_with | gene | 0.60 |
| SOD2 | associated_with | gene | 0.60 |
| MMP9 | associated_with | gene | 0.60 |
| MET | therapeutic_target | gene | 0.60 |
| Oxidative Stress | therapeutic_target | pathway | 0.60 |
| GENES | regulates | gene | 0.60 |
| MYLK | associated_with | gene | 0.60 |
| OXIDATIVE STRESS | associated_with | gene | 0.60 |
| DIABETES MELLITUS | associated_with | gene | 0.60 |
| PARKINSON'S DISEASE | associated_with | gene | 0.60 |
| INFLAMMATION | associated_with | gene | 0.60 |
| PARKINSON | associated_with | gene | 0.60 |
| Oxidative Stress | associated_with | pathway | 0.60 |
| DENND3 | regulates | gene | 0.60 |
| AND | regulates | gene | 0.60 |
| HUB GENES | regulates | gene | 0.60 |
| MGA | regulates | gene | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| SOD2 | therapeutic_target | gene | 0.60 |
| CDC42 | therapeutic_target | gene | 0.60 |
| CYCS | therapeutic_target | gene | 0.60 |
| GFAP | therapeutic_target | gene | 0.60 |
| RAC1 | regulates | gene | 0.60 |
| MET | therapeutic_target | gene | 0.60 |
| MMP9 | therapeutic_target | gene | 0.60 |
| VIM | therapeutic_target | gene | 0.60 |
| GFAP | associated_with | gene | 0.60 |
| VIM | associated_with | gene | 0.60 |
| CYCS | associated_with | gene | 0.60 |
| NCF1 | therapeutic_target | gene | 0.60 |
| DIABETES MELLITUS | associated_with | gene | 0.60 |
| PARKINSON'S DISEASE | associated_with | gene | 0.60 |
| OXIDATIVE STRESS | associated_with | gene | 0.60 |
| MGA | regulates | gene | 0.60 |
| HUB GENES | regulates | gene | 0.60 |
| DENND3 | regulates | gene | 0.60 |
| PARKINSON | therapeutic_target | gene | 0.60 |
| PARKINSON | associated_with | gene | 0.60 |
| RAC1 | co_expressed_with | protein | 0.50 |
| SOD2 | co_expressed_with | gene | 0.50 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||